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Public preferences for prioritising a COVID-19
vaccine
Jeroen Luyten, Roselinde Kessels, Sandy Tubeuf 25 November 2020
With the news of promising Covid-19 vaccines on the horizon comes a new challenge. The initial supply will not
be sufficient to vaccinate everyone and choices will need to made over distribution. This column presents the
results of an experiment in Belgium investigating people’s preferences regarding the distribution of a scarce
vaccine. There was no one single strategy that was considered best by a large majority, but three strategies
were ranked first by between 20-30% of respondents: prioritising essential workers, the chronically ill, and older
people. Libertarian-inspired approaches (such as highest willingness-to-pay or ‘first-come, first served’) and a
strict egalitarian approach (such as a lottery) were clearly the least preferred options.
While there are safe and potentially highly effective
Covid-19 vaccines on the horizon (Mahase 2020), the
supply of any successful vaccine will be limited in the
first months. How to best allocate scarce medical
resources to maximise population health and
wellbeing is a question that hovers around research in
health economics, and has been of utmost importance
throughout the Covid-19 pandemic. In an earlier
VoxEU column, Oliu-Barton and Pradelski (2020)
discussed how vaccination could be rolled out
effectively, accounting for the varying levels of
incidence of Covid-19 within a given region. Still, most vaccine allocation strategies currently being
discussed by policy institutions (National Academies 2020, World Health Organization 2020,
European Commission 2020) and experts (Persad et al. 2020, Roope et al. 2020) focus on the
characteristics of individuals. They suggest that frontline healthcare workers, highest risk people
(i.e. those above 60 years old or with coexisting conditions), essential workers, and people who live
in crowded settings and in higher risk environments should be vaccinated first. The population,
however, may have different views on who should get priority access to the vaccine. Given the
major collective dimension of the pandemic and the expected collective value of a Covid-19
vaccine, we asked members of the public who should get vaccinated first in their views (Lutyen et
al. 2020). 
Why do public preferences matter?
Public and patient involvement in healthcare decision-making is increasingly valued (Florin and
Dixon 2004). Greater public involvement in public decisions, especially those with large stakes and
a substantial ethical component, is often seen as leading to more democratic decision-making. But
public involvement is also of instrumental value. As it demonstrated with other Covid-19 measures
such as face masks (Karaivanov et al. 2020), public support plays a crucial role in making pandemic
countermeasures effective. In the case of vaccination programmes, where public participation will
be key to reach high coverage levels while, simultaneously keeping other preventive measures in
place, it is essential to develop a policy that is also supported by the general public. 
Ranking alternative vaccination strategies
We presented a representative sample of 2,060 Belgians (aged 18-80 years) with eight alternative
strategies to distribute the Covid-19 vaccines: prioritising (1) those with pre-existing medical
conditions, (2) those aged 60 and over, (3) the biggest virus spreaders, (4) working people, (5)
essential professions, (6) the fastest decision-makers (as a ‘first-come, first-served’ basis), (7) the
highest bidders (as done in a market), or (8) not prioritising anyone (using a random allocation like
in a lottery). Respondents then ranked all eight strategies from the ‘most appropriate’ to ‘least
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appropriate’ according to their opinion. Figure 1 shows how often each strategy was ranked first,
second, third, and so on using cumulative distribution functions. The least favoured options lie to the
bottom in the initial ranking positions and exhibit higher proportions in the sixth, seventh, and eighth
ranks. The figure clearly shows that there was not one single strategy that was considered best by a
large majority, but three strategies were ranked first by between 20-30% of the respondents:
prioritising essential workers, the chronically ill, and older people. On the other hand, libertarian-
inspired approaches such as highest willingness-to-pay (or ‘first-come, first served’) strategies, and
a strict egalitarian approach (such as a lottery) were clearly the least preferred options, with at least
80% of the respondents ranking them on the seventh or eight positions. Finally, targeting spreaders
or protecting the economy were strategies ranked in the middle, with virus spreaders ranked ahead
of working people in the top three most appropriate priority groups. 
Figure 1 Cumulative distribution functions of alternative COVID-19 vaccine allocation strategies
ranked from ‘most appropriate’ (rank of 1) to ‘least appropriate’ (rank of 8)
Vaccinating person A or person B?
We then asked respondents to choose whom they would vaccinate from two hypothetical
candidates. Both candidates were described by five characteristics: 
1) Their age (under 60 or 60 and over)
2) Whether their profession was an ‘essential’ one
3)Whether they had pre-existing conditions that made them vulnerable for severe Covid-19
complications and death
4) How big the economic impact or the cost to society would be because of their sickness (zero,
€100, €1,000 euros per day of sickness) and
5) How many other persons they would probably infect (one or ten persons). 
We used ‘partial profiles’, which meant that we kept two levels constant between the two choice
profiles, while three levels varied. A determinant optimal (D-optimal) statistical design selected the
best fraction of all possible partial profiles within a Bayesian framework accounting for existing prior
ordering of the attributes levels. This allowed us to examine the importance of the attributes as well
as their levels with maximum precision. A total of 30 different choice sets were generated,
consisting of two hypothetical individuals competing for vaccination. Each respondent completed
one block of ten choice sets (see Figure 2).
No subgroup had lexical priority over others. Instead, we found that three attributes were of large
importance: belonging to a medically vulnerable group due to underlying conditions, having an
‘essential profession’, and being a relatively large spreader of the virus. Having underlying
conditions was found to be the most important condition. Conversely to what was observed in the
ranking exercise, when the candidates for vaccine prioritisation were labelled with concrete
numbers (on what spreading the virus and being costly to the society meant), being aged 60 and
over was not found to be a strong predictor of priority to vaccine access by the public. 
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There are two competing first candidates for vaccine priority 
When investigating further individual heterogeneity between respondents, we identified two large
clusters of respondents within the sample.
One cluster (54%, or 1,058 respondents) of the sample was adhering to a more ‘utilitarian’ strategy
of maximising societal health outcomes by allocating vaccines strategically towards virus spreaders
(cluster one). These people also thought that vaccinating those with high economic cost to society
was to some extent relevant. The other cluster (46%, or 886 respondents) adhered to a more
‘prioritarian’ strategy and put those people who are at the highest medical risk first (cluster two).
Being a virus spreader or someone who could cost a lot to the economy was of little or no
importance in this cluster. However, both groups considered essential professions a priority group,
albeit of secondary importance to their preferred group. 
Prioritising people aged 60 or more was of minor importance in both groups, but being older than 60
received priority as the third ranked strategy in the ‘prioritarian’ group. In the ‘utilitarian’ group they
were not prioritised; Instead, preference was given to vaccinating younger people. Hence, relative to
other priority groups, many Belgians believe that age does not grant priority to Covid-19 vaccines.
Preferences for vaccination priority groups are not driven by self-interest
Membership of either cluster was not associated with most sociodemographic characteristics.
However, compared to the utilitarian cluster, respondents belonging to the prioritarian cluster were
more likely to be working, more convinced of the value of vaccines in general, more likely to accept
being vaccinated with the Covid-19 vaccine themselves, less likely to think that the vaccine
allocation strategy needed to be made only by the population, more likely to think that the
government should make these decisions, and less likely to be French-speaking. 
Conclusion
While there is almost a consensus on the priority candidates to the Covid-19 vaccines in the current
political debate, ranking within those key groups is not straightforward (as observed by the
European Commission and World Health Organization SAGE expert groups). Our evidence from
Belgium indicates some clear target groups, but it also shows that the population is unable to decide
who should be vaccinated first, second, and so on. Nonetheless, depending on the vaccine supply
that will become available, a priority ranking may be important as selected priority groups constitute
a sizeable fraction of the population already. 
Needless to say, prioritisation decisions will also have to take into account the characteristics of the
vaccines that become available. While some vaccines might have higher efficacy in reducing the
likelihood of developing a severe form of Covid-19, others may be effective in reducing
contamination risks (Lipsitch and Dean 2020). Ideally, they will do both. Similarly, some countries
will have a high transmission of the Covid-19 virus, whereas others may only have local outbreaks.
13-1-2021 Public preferences for prioritising a COVID-19 vaccine | VOX, CEPR Policy Portal
https://voxeu.org/article/public-preferences-prioritising-covid-19-vaccine 4/4
19 A A
These aspects will determine the relevance of different priority strategies at the time of vaccinating.
A successful and equitable vaccination strategy will obviously need to comprehend these specific
parameters. However, the fundamental ethical choices in vaccine allocation can already be
determined. Our study provides an insight into ethical trade-offs that policymakers might need to
make in the foreseeable future, and how the population believes these decisions should be made. 
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